Wave Life Sciences Ltd. Forecast, price target & analysts
Wave Life Sciences Ltd. Target price 2025 - Analyst rating & recommendation
Wave Life Sciences Ltd. Classifications & Recommendation:
Wave Life Sciences Ltd. Price Target
| Target Price | $19.89 |
| Price | $18.25 |
| Potential |
8.99%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Wave Life Sciences Ltd. 2026 .
The average Wave Life Sciences Ltd. target price is $19.89.
This is
8.99%
register free of charge
$37.80
107.12%
register free of charge
$9.09
50.19%
register free of charge
|
|
| A rating was issued by 20 analysts: 18 Analysts recommend Wave Life Sciences Ltd. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2026 of
8.99%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 108.30 | 43.02 |
| 4.42% | 60.28% | |
| EBITDA Margin | -97.97% | -445.19% |
| 76.20% | 354.42% | |
| Net Margin | -89.57% | -446.80% |
| 74.98% | 398.85% |
17 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Wave Life Sciences Ltd. EBITDA forecast 2025. The average Wave Life Sciences Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2025. The average Wave Life Sciences Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.70 | -1.20 |
| 29.63% | 71.43% | |
| P/E | negative |
17 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. EPS is
This results in the following potential growth metrics and future valuations:
Wave Life Sciences Ltd....
Current Wave Life Sciences Ltd. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 19 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Dec 16 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Dec 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 19 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Dec 16 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Dec 09 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Dec 09 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
